Ignite Creation Date:
2025-12-26 @ 11:08 AM
Ignite Modification Date:
2026-05-01 @ 9:43 PM
Study NCT ID:
NCT05765812
Status:
RECRUITING
Last Update Posted:
2025-12-01
First Post:
2023-02-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Sponsor:
Debiopharm International SA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Debio 0123-GBM-105
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None